[EN] SUBSTITUTED L,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES<br/>[FR] L,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES SUBSTITUÉES
                        
                            
                                申请人:ZENO ROYALTIES & MILESTONES LLC
                            
                            
                                公开号:WO2019173082A1
                            
                            
                                公开(公告)日:2019-09-12
                            
                            Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.